US EditionPublished • loading... • Updated
Risk of Infection from Anti-CD20
Summary by Multiple Sclerosis Research Blog
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Risk of Infection from Anti-CD20
Tweet I was at a meeting recently and the manufacturer of a CD20-depleting antibodies had created slides for the speaker that implied that there was no important serious infection risk with their product and I thought this doesn’t really reflect that reported by academics using rituximab. A risk factor is loss of B cells and their capacity to produce antibody. So as this happens infections can occur because the B cells that would produce antibod…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
